Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

  • Layal Chaker
  • Christine Baumgartner
  • Wendy P J den Elzen
  • M Arfan Ikram
  • Manuel R Blum
  • Tinh-Hai Collet
  • Stephan J L Bakker
  • Abbas Dehghan
  • Christiane Drechsler
  • Robert N Luben
  • Albert Hofman
  • Marileen L P Portegies
  • Marco Medici
  • Giorgio Iervasi
  • David J Stott
  • Ian Ford
  • Alexandra Bremner
  • Christoph Wanner
  • Luigi Ferrucci
  • Anne B Newman
  • Robin P Dullaart
  • José A Sgarbi
  • Graziano Ceresini
  • Rui M B Maciel
  • Westendorp, Rudi GJ
  • J Wouter Jukema
  • Misa Imaizumi
  • Jayne A Franklyn
  • Douglas C Bauer
  • John P Walsh
  • Salman Razvi
  • Kay-Tee Khaw
  • Anne R Cappola
  • Henry Völzke
  • Oscar H Franco
  • Jacobijn Gussekloo
  • Nicolas Rodondi
  • Robin P Peeters
  • Thyroid Studies Collaboration

OBJECTIVE: The objective was to determine the risk of stroke associated with subclinical hypothyroidism.

DATA SOURCES AND STUDY SELECTION: Published prospective cohort studies were identified through a systematic search through November 2013 without restrictions in several databases. Unpublished studies were identified through the Thyroid Studies Collaboration. We collected individual participant data on thyroid function and stroke outcome. Euthyroidism was defined as TSH levels of 0.45-4.49 mIU/L, and subclinical hypothyroidism was defined as TSH levels of 4.5-19.9 mIU/L with normal T4 levels.

DATA EXTRACTION AND SYNTHESIS: We collected individual participant data on 47 573 adults (3451 subclinical hypothyroidism) from 17 cohorts and followed up from 1972-2014 (489 192 person-years). Age- and sex-adjusted pooled hazard ratios (HRs) for participants with subclinical hypothyroidism compared to euthyroidism were 1.05 (95% confidence interval [CI], 0.91-1.21) for stroke events (combined fatal and nonfatal stroke) and 1.07 (95% CI, 0.80-1.42) for fatal stroke. Stratified by age, the HR for stroke events was 3.32 (95% CI, 1.25-8.80) for individuals aged 18-49 years. There was an increased risk of fatal stroke in the age groups 18-49 and 50-64 years, with a HR of 4.22 (95% CI, 1.08-16.55) and 2.86 (95% CI, 1.31-6.26), respectively (p trend 0.04). We found no increased risk for those 65-79 years old (HR, 1.00; 95% CI, 0.86-1.18) or ≥80 years old (HR, 1.31; 95% CI, 0.79-2.18). There was a pattern of increased risk of fatal stroke with higher TSH concentrations.

CONCLUSIONS: Although no overall effect of subclinical hypothyroidism on stroke could be demonstrated, an increased risk in subjects younger than 65 years and those with higher TSH concentrations was observed.

OriginalsprogEngelsk
TidsskriftJournal of Clinical Endocrinology and Metabolism
Vol/bind100
Udgave nummer6
Sider (fra-til)2181-2191
Antal sider11
ISSN0021-972X
DOI
StatusUdgivet - jun. 2015

ID: 140395294